【轉發】【火熱註冊中】波士頓2024中國科學技術大學校友峰會

波士頓2024中國科學技術大學校友峰會
各位校友:
    波士頓作為全球教育、科技與創新的中心之一,為我們提供了一個獨特的平臺,共同展望科技前景,匯聚校友的智慧與力量。本次波士頓科技峰會將涵蓋四大主題:金融投資生物醫藥人工智慧社會法律,旨在為校友們呈現一場富有啟發和促進交流的知識盛宴。我們邀請了來自學術界和工業界的傑出校友,與校友們分享他們的科研成果、發展經歷和行業見解。透過深入探討,我們將共同探索這些領域的機遇與挑戰,併為未來發展獻計獻策。
    除了精彩的講座之外,這次峰會我們還提供免費的午餐茶歇飯後甜點。在輕鬆愉快的氛圍中,您可以享用美味的食物與老友暢談。讓我們相聚波士頓,共襄科技盛宴,共同開啟一段探索未知、創造未來的旅程!同時我們歡迎校友們積極參與贊助,為峰會的順利舉辦貢獻力量。2024科技峰會的詳細議程將由波士頓校友會後續公佈,敬請期待。
活動地點: MIT Stata center Room 32-155 (32 Vassar St, Cambridge, MA 02139)
活動時間: 9:00AM – 3:00PM, Oct. 27th, 2024 (Sunday)
活動聯絡人:
李明達 (1802): molecule.li [at] outlook.com
姜麗桐 (10203): jianglitong [at] ustc.edu
購票資訊
票價資訊
Ticket type Student/Scholar (Alumni) Professional (Alumni)

General 

(Non-Alumni)

Early-bird 15 20 25
Regular 30 40 60
(Early-bird ticket截止至10月20日;Regular ticket截止至10月25日)
報名連結
https://www.eventbrite.com/e/2024-boston-ustc-alumni-summit-tickets-1019915794597
或點選閱讀原文
活動地點
波士頓2024年中國科學技術大學校友峰會將在MIT的MIT Stata Center Room 32-155 (32 Vassar St, Cambridge, MA 02139) 舉辦,我們屆時會有志願者在門口指引大家到活動的教室。
附近停車場:Albany Street Parking Garage (36 Albany St, Cambridge, MA 02139),$11/day for weekends
MIT Stata Center 衛星地圖
MIT Stata Center 外部
嘉賓介紹
George Dai (8212)
Chief Investment Officer
Weatherbie Capital
George Dai is Chief Investment Officer and Portfolio Manager of Weatherbie Capital, LLC. George is a Portfolio Manager on the Weatherbie Specialized Growth, Weatherbie Long/Short, Alger Dynamic Opportunities and Weatherbie Enduring Growth Strategies. George joined Weatherbie Capital in March 2001 and has 25 years of investment experience. During his tenure at Weatherbie, he has been featured and quoted in several publications such as: The New York Times, Investor’s Business Daily, Barron’s, Reuters, Business Insider and Bloomberg. Prior to joining Weatherbie, he was an equity analyst with 1838 Investment Advisors. George received his M.B.A. from the Wharton School, University of Pennsylvania, (Director’s List), and his Ph.D. in chemistry from Johns Hopkins University. Previously, he earned a B.S. from the University of Science and Technology of China and was a pharmaceutical research scientist at Procter & Gamble. George is a prized Bridge player, and he holds four U.S. patents.
Philip Zhang 張引 (8103)
JD/PhD, Managing Principal
Milstein Zhang & Wu LLC
Dr. Zhang is Managing Principal of Milstein Zhang & Wu LLC, a law firm he co-founded in 2009. Dr. Zhang has 25 years of experience representing private and public companies and research institutions, particularly in the areas of pharmaceuticals, medical devices and advanced materials, including advising clients on IP strategies, worldwide patent procurement, patent validity and freedom-to-operate, and technology licensing.  Dr. Zhang received his J.D. from Vanderbilt University Law School in 1999, his Ph.D. (organic chemistry) from Dartmouth College in 1995, and graduated from the University of Science & Technology of China in 1986.
Lixin Gao 高立新 (8100)
Professor, Department of Electrical and Computer Engineering
University of Massachusetts, Amherst
Lixin Gao is a University Distinguished Professor of Electrical and Computer Engineering at the University of Massachusetts at Amherst. She received a Ph.D. degree in Computer Science from the University of Massachusetts at Amherst. Her research interests include online social networks, and Internet routing, network virtualization and cloud computing. Between May 1999 and January 2000, she was a visiting researcher at AT&T Research Labs and DIMACS. She was an Alfred P. Sloan fellow between 2003-2005, received an NSF CAREER Award in 1999 and a fellowship from Harvard University Radcliffe Institute in 2021. She won the best paper award from IEEE INFOCOM 2010, and the test-of-time award in ACM SIGMETRICS 2010. Her paper in ACM Cloud Computing 2011 was honored with “Paper of Distinction”.  She is a fellow of IEEE and ACM.
Jianwei Che 車健為 (8803)
Group leader, Center for Protein Degradation,
Director, Computational Chemistry Core,
Dana-Farber Cancer Institute
Jianwei Che, PhD is a group leader at the Center for Protein Degradation of Dana-Farber Cancer Institute (DFCI) and the director of computational chemistry core in the Department of Cancer Biology. Dr. Che’s research is focused on developing and applying molecular modeling and informatics methods for the discovery and optimization of selective small molecules for modulating protein functions.
Dr. Che leads a computational group in collaboration with chemists, structural biologists, and cell biologists to identify and optimize novel small molecules that target disease-relevant proteins such as kinases, E3 ligases, and transcription factors. Currently, his main research interests include covalent small molecule discovery and small molecule-induced protein-protein interactions, such as molecular glues. Prior to joining DFCI, Dr. Che led technology development for sensitive detection of cancer mutations in circulating tumor DNA from plasma samples at M3Bio, using molecular barcoding in library construction and sequencing data analysis. He was also a senior research investigator at the Genomics Institute of Novartis Research Foundation, where he applied various molecular modeling methods in small molecule drug discovery projects and biomarker research. Additionally, he is a scientific co-founder of matchpoint ther. Dr. Che has published over 90 peer reviewed scientific publications and is an inventor in many patents.
Peng Yi 伊鵬 (9808)
Assistant Professor, Joslin Diabetes Center
Harvard Medical School
Peng Yi was a student in 9808 (98207) from USTC. He earned his Ph.D. in genetics from UT Southwestern Medical Center and then completed postdoctoral training in the Department of Molecular and Cell Biology at Harvard University. He is currently an investigator at the Joslin Diabetes Center, an Assistant Professor of Medicine at Harvard Medical School, and an affiliated faculty member at the Harvard Stem Cell Institute. His lab is interested in researching pancreatic beta cell regeneration and protection against autoimmunity, aiming to understand the underlying mechanisms of Type 1 diabetes and find potential treatments or cures.
Wayne Ye 葉萬瑜 (0204)
President, Dolphin Capital
Wayne Ye is an angel investor, portfolio manager, entrepreneur and Ph.D. in Particle Physics. Dr. Ye has rich experience in quantitative research, trading, venture investing and post-investment management. He conducted research and portfolio management in multiple renowned funds including Millennium Partners, and is currently heading the investment and recruitment efforts for his firm.
Jiang He 何江 (0508)
Co-founder, Senior Director of Scientific Affairs, Vizgen
Jiang He is the scientific co-founder and VP of R&D, Reagents in Vizgen, a life science company pioneering in single-cell spatial genomics. He completed his postdoc at MIT, Ph.D. at Harvard University in Xiaowei Zhuang’s lab, and B.S. from University of Science and Technology of China. His work focused on developing single molecule imaging techniques and applying them to study different biological processes. Within Vizgen, Jiang oversees the reagent and product development, as well as the lab service division. Jiang has been recognized with numerous awards including Forbes 30 under 30 in Healthcare, Spotlight Scholar at AIF, and STAT Wunderkind awardee. Jiang was also the Commencement Speaker at Harvard University in 2016, the first Chinese graduate to ever speak at Harvard’s commencement ceremony. His speech “The spider’s bite” argued the importance of disseminating the scientific knowledge to where it’s most needed. In addition to his academic efforts, Jiang has written a non-fictional book about rural China, titled Zouchu Zijide Tiankong (Walking Out a Way of My Own), to raise awareness of the living and health conditions of resource-limited regions in China. His story has been broadly covered by many media outlets, including the Forbes, Boston Globe, Huffington Post, Harvard Crimson, MIT News, Sixth Tone, Asia Times, Global Times, People’s Daily, China Daily, Sina News, Yahoo News, Tecent News, CCTV, HunanTV, and many others.
Jiawei Zhang 張佳偉 (1101)
Assistant Professor, Computer Science
University of Wisconsin, Madison
Jiawei Zhang is an incoming assistant professor in the Department of Computer Sciences at the University of Wisconsin–Madison. Currently, he is a postdoctoral fellow supported by The MIT Postdoctoral Fellowship For Engineering Excellence in the Laboratory for Information & Decision Systems (LIDS) at MIT, working with Prof. Asuman Ozdaglar and Prof. Saurabh Amin. He obtained the Ph.D. degree in Computer and Information Engineering from the Chinese University of Hong Kong, Shenzhen, with an advisory of Prof. Zhi-Quan (Tom) Luo, and was honored with the Presidential Award for Outstanding Doctoral Students. Previously, he obtained the B.Sc. in Mathematics (Hua Loo-Keng Talent Program) from the University of Science and Technology of China. His research interests include: • Optimization theory and algorithms with application to machine learning, energy, and signal processing • Optimization, generalization, and robustness of machine learning, reinforcement learning, generative models (including diffusion models, large models, foundation models)
近兩年中國科大波士頓峰會回顧

相關文章